ID   5555
AC   CVCL_E9CJ
RX   DOI=10.4161/intv.24790;
RX   PubMed=25873177;
RX   PubMed=26414886;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=25873177).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Breed/subspecies: C57BL/6 BRAF+/LSL-BRAFV600E;Tyr::CreERT2+/o transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   DOI=10.4161/intv.24790;
RA   Manning, Cerys S.
RA   Jenkins, Robert P.
RA   Hooper, Steven
RA   Gerhardt, Holger
RA   Marais, Richard
RA   Adams, Susanne
RA   Adams, Ralf Heinrich
RA   van Rheenen, Jacco
RA   Sahai, Erik
RT   "Intravital imaging reveals conversion between distinct tumor vascular
RT   morphologies and localized vascular response to Sunitinib.";
RL   IntraVital 2:e24790.1-e24790.13(2013).
//
RX   PubMed=25873177; DOI=10.1016/j.ccell.2015.03.008; PMCID=PMC4402404;
RA   Hirata, Eishu
RA   Girotti, Maria Romina
RA   Viros, Amaya
RA   Hooper, Steven
RA   Spencer-Dene, Bradley
RA   Matsuda, Michiyuki
RA   Larkin, James
RA   Marais, Richard
RA   Sahai, Erik
RT   "Intravital imaging reveals how BRAF inhibition generates
RT   drug-tolerant microenvironments with high integrin beta1/FAK
RT   signaling.";
RL   Cancer Cell 27:574-588(2015).
//
RX   PubMed=26414886; DOI=10.1111/pcmr.12424; PMCID=PMC4737278;
RA   Seifert, Heike
RA   Hirata, Eishu
RA   Gore, Martin Eric
RA   Khabra, Komel
RA   Messiou, Christina
RA   Larkin, James
RA   Sahai, Erik
RT   "Extrinsic factors can mediate resistance to BRAF inhibition in
RT   central nervous system melanoma metastases.";
RL   Pigment Cell Melanoma Res. 29:92-100(2016).
//